Inbakicept is an IL-15 receptor activator, consisting of IL-15 mutant and IL-15Ralpha-Fc fusion. Inbakicept magnifies anti-CD20 mAb-mediated NK-cell responses and antibody-dependent cellular cytotoxicity (ADCC). Inbakicept also increases degranulation, IFNgamma production in cells.
Reinheit:
>98.5%
CAS Nummer:
[2135939-52-3]
Target-Kategorie:
IL Receptor/Related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
